Inbrija Interactions
There are 520 drugs known to interact with Inbrija (levodopa), along with 11 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 50 are major, 459 are moderate, and 11 are minor.
- View all 520 medications that may interact with Inbrija
- View Inbrija alcohol/food interactions (1)
- View Inbrija disease interactions (11)
Most frequently checked interactions
View interaction reports for Inbrija (levodopa) and the medicines listed below.
- acetaminophen
- amantadine
- aspirin
- bupropion
- carbidopa / levodopa
- clonazepam
- CoQ10 (ubiquinone)
- Crexont (carbidopa / levodopa)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- gabapentin
- Gocovri (amantadine)
- levothyroxine
- lisinopril
- magnesium oxide
- melatonin
- metoprolol
- MiraLAX (polyethylene glycol 3350)
- Myrbetriq (mirabegron)
- Neupro (rotigotine)
- omeprazole
- pantoprazole
- ropinirole
- Rytary (carbidopa / levodopa)
- sertraline
- Sinemet (carbidopa / levodopa)
- trazodone
- Tylenol (acetaminophen)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
Inbrija alcohol/food interactions
There is 1 alcohol/food interaction with Inbrija (levodopa).
Inbrija disease interactions
There are 11 disease interactions with Inbrija (levodopa) which include:
- cardiac disease
- neuroleptic malignant syndrome
- psychoses/depression
- glaucoma
- liver/renal
- melanoma
- reactive airway disease
- sleep disorders
- hypotension
- psychosis
- GI bleeding
Report options
QR code containing a link to this page
More about Inbrija (levodopa)
- Inbrija consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: dopaminergic antiparkinsonism agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
